Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. AZN
7. HOOD
8. QQQ
9. ACN
10. NVS

Go back to Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 54.07 -0.9 (1.64%)
Previous Close $54.97    52 Week High $35.13 
Open $54.24    52 Week Low $28.10 
Day High $54.42    P/E N/A 
Day Low $53.87    EPS $0.00 
Volume 1,300,742       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

ROGERS CORPORATION (NYSE: ROG) Delayed: 129.50 +1.68 (1.31%)
Previous Close $127.82    52 Week High $76.55 
Open $128.55    52 Week Low $41.92 
Day High $130.44    P/E 73.16 
Day Low $127.33    EPS $1.77 
Volume 137,876       

Roper Industries (NASDAQ: ROP) Delayed: 395.65 -11.63 (2.86%)
Previous Close $407.28    52 Week High $195.93 
Open $401.92    52 Week Low $155.79 
Day High $403.00    P/E 73.68 
Day Low $393.65    EPS $5.37 
Volume 585,759